4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Filana Therapeutics, Inc. (FLNA) operates in the Biotechnology industry and is headquartered in Austin, United States with about 17 employees. Its market capitalization is roughly $57 million. In the fiscal year ended 2025-12-31, FLNA reported $0M in revenue and ($91M) in net income.
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($96M) | ($142M) | ($107M) | ($82M) | — |
| Net Income | ($91M) | ($24M) | ($97M) | ($76M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($11M) | ($14M) | ($12M) | ($45M) | ($25M) | — |
| Net Income | ($10M) | ($12M) | ($11M) | ($44M) | ($23M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $118M | $158M | $152M | $235M | — |
| Total Liabilities | $44M | $12M | $14M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FLNA viewer.
About TickerBase · Data methodology & sources